Evolving Treatment Paradigms for Oropharyngeal Squamous Cell Carcinoma
Oropharyngeal squamous cell carcinoma (OPSCC) is increasing in incidence in the United States and in many countries worldwide primarily as a result of increasing rates of human papillomavirus (HPV) infection. HPV-positive OPSCC represents a distinct disease entity from head and neck squamous cell ca...
Main Authors: | Ryan K. Cleary, Anthony J. Cmelak |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2016-11-01
|
Series: | Journal of Global Oncology |
Online Access: | http://ascopubs.org/doi/10.1200/JGO.2016.006304 |
Similar Items
-
Deintensification of radiotherapy in oropharyngeal carcinoma of squamous cells
by: Carolina Hermosilla Pizarro, et al.
Published: (2021-01-01) -
An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma
by: Yaxuan Huang, et al.
Published: (2022-03-01) -
The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy
by: P. Morbini, et al.
Published: (2019-02-01) -
Editorial: Considerations in the surgical management of HPV-positive oropharyngeal squamous cell carcinoma
by: Jon Mallen-St Clair, et al.
Published: (2023-06-01) -
Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors
by: Peter L. Stern, et al.
Published: (2021-06-01)